UNSPSC 51172113: Ambucetamide or ambucetamide hydrochloride

This classification denotes an antispasmotic agent with the molecular formulas C17H28N2O2 and C17H28N2O2.ClH, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 131B408RZI and 2M010V3MAJ, the base compound being chemically known as benzeneacetamide, alpha-(dibutylamino)-4-methoxy- (9ci) but generally known as ambucetamide, which bears US NIH Compound Identifier 10616. European Medicines Agency schedules Ambucetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05400MIG and SUB00428MIG.

UNSPSC 51172113 Ambucetamide or ambucetamide hydrochloride is a Commodity code with minimal recent state and local procurement activity directly aligned to the pharmaceutical product itself. The single recent opportunity posted under this code—Collin County Community Supervision and Corrections Department RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026—involves drug testing operations rather than procurement of ambucetamide as a finished pharmaceutical or chemical reagent. The scope encompasses staffing collection sites, operating an Interactive Voice Response notification system, conducting immunoassay screening with LC/MS/MS or GC/MS confirmation, and alternative testing methodologies including oral fluid and hair analysis, with approximately 25,031 annual tests across five-panel and six-panel screens. The contract represents a service outsourcing rather than direct chemical supply, suggesting the code may be misaligned with the actual commodity being procured or that state and local jurisdictions rarely issue standalone RFPs for this specific chemical compound.

Collin County, Texas is the sole recent issuer identified, with an estimated contract value of $600,000 over two years with up to three optional one-year renewals. The successful vendor must maintain lab certification from SAMHSA, Texas Department of Public Safety, or CAP, and pricing is structured on a per-test basis with three service models: screening only, confirmation after screening, and screening with automatic confirmation of positives. No other states or municipalities show recent activity under this code in the available record. Business development professionals should monitor whether this code is being systematically used for drug-testing-program outsourcing in other criminal justice jurisdictions or whether future opportunities will surface for direct ambucetamide chemical procurement at the state or local level.